Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance

EBioMedicine

Volumn 2, Issue 2, 2015, Pages 165-171

  Li, Haitao ^a,b   Liu, Kangdong ^b,c   Boardman, Lisa A ^d   Zhao, Yuzhou ^c   Wang, Lei ^a   Sheng, Yuqiao ^a   Oi, Naomi ^a   Limburg, Paul J ^d   Bode, Ann M ^a   Dong, Zigang ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b The China US   (China)

^c ZHENGZHOU UNIVERSITY   (China)

^d MAYO CLINIC   (United States)

Author keywords

Colorectal cancer; Familial adenomatous polyposis; Thromboxane A2

Indexed keywords

11 OXOTHROMBOXANE B2; ACETYLSALICYLIC ACID;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BIOPSY; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME IMMUNOASSAY; FAMILIAL COLON POLYPOSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; URINALYSIS; WESTERN BLOTTING;

EID: 84943234261     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2014.12.004     Document Type: Article

References (21)

1. Algra A.M., Rothwell P.M. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012, 13(5):518-527.
2. Castellone M.D., Teramoto H., Williams B.O., Druey K.M., Gutkind J.S. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005, 310(5753):1504-1510.
3. Chan A.T., Ogino S., Fuchs C.S. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl. J. Med. 2007, 356(21):2131-2142.
4. 2. Science 2002, 296(5567):539-541.
5. Chulada P.C., Thompson M.B., Mahler J.F., Doyle C.M., Gaul B.W., Lee C., et al. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res. 2000, 60(17):4705-4708.
6. Daikoku T., Wang D., Tranguch S., Morrow J.D., Orsulic S., DuBois R.N., et al. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 2005, 65(9):3735-3744.
7. deVos T., Tetzner R., Model F., Weiss G., Schuster M., Distler J., et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin. Chem. 2009, 55(7):1337-1346.
8. Dovizio M., Tacconelli S., Ricciotti E., Bruno A., Maier T.J., Anzellotti P., et al. Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis. J. Pharmacol. Exp. Ther. 2012, 341(1):242-250.
9. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
10. Li H., Zhu F., Chen H., Cheng K.W., Zykova T., Oi N., et al. 6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1. Cancer Res. 2014, 74(1):243-252.
11. Markowitz S.D., Bertagnolli M.M. Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med. 2009, 361(25):2449-2460.
12. McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(1):272-277.
13. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87(5):803-809.
14. Rothwell P.M., Wilson M., Elwin C.E., Norrving B., Algra A., Warlow C.P., et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010, 376(9754):1741-1750.
15. Siegel R., Desantis C., Jemal A. Colorectal cancer statistics, 2014. CA Cancer J. Clin. 2014, 64(2):104-117.
16. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 2014, 64(1):9-29.
17. Sonoshita M., Takaku K., Sasaki N., Sugimoto Y., Ushikubi F., Narumiya S., et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(delta 716) knockout mice. Nat. Med. 2001, 7(9):1048-1051.
18. Sorensen H.T., Mellemkjaer L., Olsen J.H., Baron J.A. Prognosis of cancers associated with venous thromboembolism. N. Engl. J. Med. 2000, 343(25):1846-1850.
19. Srivastava S., Verma M., Henson D.E. Biomarkers for early detection of colon cancer. Clin. Cancer Res. 2001, 7(5):1118-1126.
20. Vong L., Ferraz J.G., Panaccione R., Beck P.L., Wallace J.L. A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(26):12023-12027.
21. Wang D., Dubois R.N. Eicosanoids and cancer. Nat. Rev. Cancer 2010, 10(3):181-193.